SYNCELL

Taipei, Taiwan Founded: 2020 • Age: 6 yrs
Microscopic systems for protein and biomarker identification are developed.
Request Access

About SYNCELL

SYNCELL is a company based in Taipei (Taiwan) founded in 2020 by Jung Chi Liao.. SYNCELL has raised $15 million across 1 funding round from investors including Taiwania Capital. SYNCELL offers products and services including Microscoop and Reagent Kits. SYNCELL operates in a competitive market with competitors including Nearfield Instruments, Delmic B.V., FlowVIEW Tek, Tiny Bright Things and Envue, among others.

  • Headquarter Taipei, Taiwan
  • Founders Jung Chi Liao
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Syncell Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $15 M (USD)

    in 1 rounds

  • Latest Funding Round
    $15 M (USD), Series A

    Dec 11, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SYNCELL

SYNCELL offers a comprehensive portfolio of products and services, including Microscoop and Reagent Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enables high-precision proteomic discovery at cellular and subcellular levels.

Optimized kits for spatial protein purification and integration with platforms.

People of SYNCELL
Headcount 10-50
Employee Profiles 13
Employee Profiles
People
Nikhil Rao
Chief Commercial Officer (cco)
People
Mario Scheel-Werner
Director Business Development / Head Of Sales EMEA
People
Michelli Faria de Oliveira
Sr. Applications Manager
People
Jennie Wu
Marketing Communication Assistant Manager

Unlock access to complete

Funding Insights of SYNCELL

SYNCELL has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series A round of $15 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $15.0M
  • First Round

    (11 Dec 2024)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2024 Amount Series A - SYNCELL Valuation Taiwania Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in SYNCELL

SYNCELL has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Taiwania Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
VC firm focusing on technology companies
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by SYNCELL

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - SYNCELL

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Syncell Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of SYNCELL

SYNCELL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nearfield Instruments, Delmic B.V., FlowVIEW Tek, Tiny Bright Things and Envue, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
High-throughput atomic force microscopy systems for 3D metrology are developed.
domain founded_year HQ Location
Provider of light and electron microscopy solutions for life sciences and materials science
domain founded_year HQ Location
Liquid monitoring, analysis, and particle detection systems are provided.
domain founded_year HQ Location
Microscopy tools for nanoscale imaging and measurement are provided.
domain founded_year HQ Location
Nanofluidic scattering microscopy technology for biomolecule imaging is provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Syncell

Frequently Asked Questions about SYNCELL

When was SYNCELL founded?

SYNCELL was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Where is SYNCELL located?

SYNCELL is headquartered in Taipei, Taiwan.

Who is the current CEO of SYNCELL?

Jung Chi Liao is the current CEO of SYNCELL. They have also founded this company.

Is SYNCELL a funded company?

SYNCELL is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series A of $15M, raised on Dec 11, 2024.

What does SYNCELL do?

SYNCELL was founded in 2020 in Taipei, Taiwan, within the biotechnology sector. A microscopic platform called Microscoop is developed for identifying and quantifying proteins and biomarkers. Proprietary optoproteomics technology is employed, along with automated AI-based recognition algorithms and photochemical labeling reagents. These tools support discovery research and investigations into disease mechanisms, focusing on novel protein analysis.

Who are the top competitors of SYNCELL?

SYNCELL's top competitors include Nearfield Instruments, Delmic B.V. and Fluid Imaging Technologies.

What products or services does SYNCELL offer?

SYNCELL offers Microscoop and Reagent Kits.

Who are SYNCELL's investors?

SYNCELL has 1 investor. Key investors include Taiwania Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available